Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-30 @ 11:14 PM
Study NCT ID:
NCT00229203
Status:
COMPLETED
Last Update Posted:
2009-12-24
First Post:
2005-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
Sponsor:
PharmaMar
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APL-B-014-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
PharmaMar USA Inc.
Old Organization:
PharmaMar USA Inc.